← Browse by Condition
Medical Condition
cardiomyopathy hypertrophic
Total Trials
3
Recruiting Now
3
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for cardiomyopathy hypertrophic sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
2 trials
1 trial
NCT05610215
Recruiting
Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy
Enrollment
66 pts
Location
China
Sponsor
China National Center for Card...
NCT02696135
Recruiting
The Chinese Hypertrophic Cardiomyopathy Study(CHCS)
Enrollment
3,000 pts
Location
China
Sponsor
China National Center for Card...
NCT07077005
Recruiting
Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy
Enrollment
24 pts
Location
Germany
Sponsor
Technical University of Munich
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology